Assessing The Potential Cost Saving Potential of Implementing Benepali®, An Etanercept Biosimilar, Using Discount Agreements For The Treatment of All Licensed Etanercept Indications For Adults In Sweden
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1086
https://www.valueinhealthjournal.com/article/S1098-3015(16)32452-4/fulltext
Title :
Assessing The Potential Cost Saving Potential of Implementing Benepali®, An Etanercept Biosimilar, Using Discount Agreements For The Treatment of All Licensed Etanercept Indications For Adults In Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32452-4&doi=10.1016/j.jval.2016.09.1086
First page :
A533
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1016